![Foto de ROBERTO](/img/uploaded/6DF5DBACE07AC35328CBBA37C2E80A2A.jpg)
ROBERTO
PALACIOS RAMIREZ
PERSONAL INVESTIGADOR POSDOCTORAL
Publications (22) Publications de ROBERTO PALACIOS RAMIREZ
2023
-
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
International Journal of Molecular Sciences, Vol. 24, Núm. 3
-
Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence
International Journal of Molecular Sciences, Vol. 24, Núm. 7
-
Multiomics insights on the onset, progression, and metastatic evolution of breast cancer
Frontiers in Oncology, Vol. 13
2022
-
Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice
Frontiers in Physiology, Vol. 13
2020
-
Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade
Journal of Investigative Dermatology, Vol. 140, Núm. 1, pp. 223-234.e7
2019
-
Egg White Hydrolysate: A new putative agent to prevent vascular dysfunction in rats following long-term exposure to aluminum
Food and Chemical Toxicology, Vol. 133
-
Egg white hydrolysates improve vascular damage in obese Zucker rats by its antioxidant properties
Journal of Food Biochemistry, Vol. 43, Núm. 12
-
MR (Mineralocorticoid Receptor) Induces Adipose Tissue Senescence and Mitochondrial Dysfunction Leading to Vascular Dysfunction in Obesity
Hypertension, Vol. 73, Núm. 2, pp. 458-468
-
Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway
Scientific Reports, Vol. 9, Núm. 1
2018
-
Mitochondrial oxidative stress in obesity: Role of the mineralocorticoid receptor
Journal of Endocrinology, Vol. 238, Núm. 3, pp. R143-R159
-
NADPH Oxidase 5 Is a pro-contractile nox isoform and a point of cross-talk for calcium and redox signaling-implications in vascular function
Journal of the American Heart Association, Vol. 7, Núm. 12
2017
2016
-
Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension
British Journal of Pharmacology, Vol. 173, Núm. 9, pp. 1541-1555
-
Spironolactone prevents endothelial nitric oxide synthase uncoupling and vascular dysfunction induced by β-adrenergic overstimulation
Hypertension, Vol. 68, Núm. 3, pp. 726-735
2015
-
Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through nox-dependent processes
Journal of Pharmacology and Experimental Therapeutics, Vol. 353, Núm. 1, pp. 27-34
-
Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension
British Journal of Pharmacology, Vol. 172, Núm. 12, pp. 3159-3176
2014
-
Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats
American Journal of Physiology - Heart and Circulatory Physiology, Vol. 306, Núm. 11
-
Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production
PLoS ONE, Vol. 9, Núm. 8
2012
-
Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress
Journal of Hypertension, Vol. 30, Núm. 2, pp. 315-326